Similarly, EPO also reduced post-ischemic upregulated mRNA levels of IL-1β at both reperfusion timepoints, while the other cleavage product of inflammasomes, IL-18, did not appear to be affected by either ischemia or EPO administration (Fig. 2H). The gene discussed is EPO; the disease is ischemia.